FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Buell Jennifer

2. Date of Event Requiring Statement (MM/DD/YYYY)
6/29/2017 

3. Issuer Name and Ticker or Trading Symbol

AGENUS INC [AGEN]

(Last)        (First)        (Middle)

3 FORBES ROAD

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                            _____ 10% Owner
___ X ___ Officer (give title below)          _____ Other (specify below)
VP Research & External Affairs /

(Street)

LEXINGTON, MA 02421       

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)

 

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock   24361   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option, right to buy   9/3/2014   (1) 9/3/2023   Common Stock   32500   $3.68   D    
Restricted Stock Unit   9/3/2017   9/3/2017   Common Stock   4375   $0   D    
Stock Option, right to buy   2/14/2017   2/14/2024   Common Stock   100000   $3   D    
Stock Option, right to buy   5/12/2015   (2) 2/12/2025   Common Stock   24500   $5.04   D    
Stock Option, right to buy   2/12/2015   2/12/2025   Common Stock   10500   $5.04   D    
Restricted Stock Unit     (3) 3/31/2019   Common Stock   16000   $0   D    
Stock Option, right to buy   3/31/2017   (4) 3/31/2026   Common Stock   100000   $4.16   D    
Stock Option, right to buy   3/31/2018   (5) 3/31/2027   Common Stock   125000   $3.77   D    

Explanation of Responses:
(1)  Option awarded in accordance with the Agenus Inc. Amended and Restated 2009 Equity Plan vesting in 4 equal annual installments beginning September 3, 2014, the first anniversary of the grant date.
(2)  Option awarded in accordance with the Agenus Inc. Amended and Restated 2009 Equity Plan vesting in 12 quarterly installments from February 12, 2015, the date of grant.
(3)  Award granted in accordance with the Agenus Inc. Amended and Restated 2009 Equity Plan and is eligible to vest in a single installment on March 31, 2019 based upon Company stock price performance. Amount shown reflects the target award. The ultimate award size can range between 50% and 150% of the target based on the actual average stock price achieved.
(4)  Option awarded in accordance with the Agenus Inc. Amended and Restated 2009 Equity Plan and vests over three years with one-third vested on March 31, 2017 and the balance in equal quarterly installments thereafter.
(5)  Option awarded in accordance with the Agenus Inc. Amended and Restated 2009 Equity Plan vesting one-third on the one-year anniversary of the grant date, March 31, 2017, with the balance vesting in equal quarterly installments thereafter.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Buell Jennifer
3 FORBES ROAD
LEXINGTON, MA 02421


VP Research & External Affairs

Signatures
Christine M. Klaskin, by Power of Attorney 7/7/2017
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Agenus (NASDAQ:AGEN)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Agenus Charts.
Agenus (NASDAQ:AGEN)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Agenus Charts.